Summary

Neurodegeneration refers to the progressive loss of neuron structure or function, which may eventually lead to cell death. Many neurodegenerative diseases, such as amyotrophic lateral sclerosis, multiple sclerosis, Parkinson's disease, Alzheimer's disease, Huntington's disease and prion disease, are the results of neurodegenerative processes. Neurodegeneration can be found in many different levels of neuronal circuits in the brain, from molecules to systems. Since there is no known method to reverse the progressive degeneration of neurons, these diseases are considered incurable. Biomedical research has revealed many similarities between these diseases at the subcellular level, including atypical protein assembly (such as protein diseases) and induction of cell death. These similarities indicate that progress in the treatment of one neurodegenerative disease may also improve other diseases. This collection of entries aims to collect various medical research results related to neurodegeneration. We invite researchers to share their new results and ideas related to neurodegeneration.

Expand All
Entries
Topic Review
Nanoparticles in Cancer Therapies and Clinical Diagnosis
Timely diagnosis and appropriate antitumoral treatments remain of utmost importance, since cancer remains a leading cause of death worldwide. Within this context, nanotechnology offers specific benefits in terms of cancer therapy by reducing its adverse effects and guiding drugs to selectively target cancer cells.
  • 491
  • 23 Nov 2023
Topic Review
The Kappa Opioid Receptor for Multiple Sclerosis
Multiple sclerosis (MS) afflicts millions of people worldwide. While multiple therapeutics have recently been developed and approved as treatment agents, they are not 100% effective. Recent developments investigating the endogenous opioid system involvement in MS has revealed that agonists of the kappa opioid receptor (KOR) have beneficial effects in both animal models of MS (and demyelinating disorders more generally) as well as in vitro models of remyelination. Several groups have contributed to this development.
  • 471
  • 17 Nov 2023
Topic Review
Migraine with Aura
A sizable portion of the world’s population suffers from migraines with aura. Estrogen is crucial in migraine pathophysiology, especially in women, which might be used to develop hormone-regulating medications. Migraine’s underlying mechanism or visual abnormalities may explain migraine sufferers’ variations in brain activity or visual system processing.
  • 410
  • 16 Nov 2023
Topic Review
Nerve Growth Factor and Autoimmune Diseases
Nerve growth factor (NGF) plays a crucial immunomodulatory role and increased levels are found in numerous tissues during autoimmune states. NGF directly modulates innate and adaptive immune responses of B and T cells and causes the release of neuropeptides and neurotransmitters controlling the immune system activation in inflamed tissues. Evidence suggests that NGF is involved in the pathogenesis of numerous immune diseases including autoimmune thyroiditis, chronic arthritis, multiple sclerosis, systemic lupus erythematosus, mastocytosis, and chronic granulomatous disease. Furthermore, as NGF levels have been linked to disease severity, it could be considered an optimal early biomarker to identify therapeutic approach efficacy. In conclusion, by gaining insights into how these molecules function and which cells they interact with, future studies can devise targeted therapies to address various neurological, immunological, and other disorders more effectively. This knowledge may pave the way for innovative treatments based on NGF manipulation aimed at improving the quality of life for individuals affected by diseases involving neurotrophins.
  • 460
  • 16 Nov 2023
Topic Review
Mitochondrial Dysfunction in Amyotrophic Lateral Sclerosis Pathogenesis
Mitochondrial dysfunction occurs in numerous neurodegenerative diseases, particularly amyotrophic lateral sclerosis (ALS), where it contributes to motor neuron (MN) death. Of all the factors involved in ALS, mitochondria have been considered as a major player, as secondary mitochondrial dysfunction has been found in various models and patients. 
  • 470
  • 14 Nov 2023
Topic Review
Effect of Anthocyanins on Neurological Disorders
Anthocyanins are a type of flavonoids that give plants and fruits their vibrant colors. They are known for their potent antioxidant properties and have been linked to various health benefits. Due to their ability to modulate mechanisms implicated in the onset of neurological diseases, anthocyanins hold significant potential for treating such conditions.
  • 547
  • 14 Nov 2023
Topic Review
Graph Neural Networks for Parkinson’s Disease
Graph neural networks (GNNs) have been increasingly employed in the field of Parkinson’s disease (PD) research. The use of GNNs provides a promising approach to address the complex relationship between various clinical and non-clinical factors that contribute to the progression of PD. 
  • 446
  • 13 Nov 2023
Topic Review
Beneficial Mechanisms of Physical Exercise in Alzheimer’s Disease
Physical exercise has emerged as a promising non-pharmacological intervention for Alzheimer’s disease (AD), with demonstrated effects on promoting neurogenesis, activating neurotrophic factors, reducing Aβ aggregates, minimizing the formation of neurofibrillary tangles (NFTs), dampening inflammatory processes, mitigating oxidative stress, and improving the functionality of the neurovascular unit (NVU). Overall, the neuroprotective effects of exercise are not singular, but are multi-targets. 
  • 583
  • 08 Nov 2023
Topic Review
Apolipoprotein D in Neuropsychiatric Disorders
Neuropsychiatric disorders (NDs) are a diverse group of pathologies, including schizophrenia or bipolar disorders, that directly affect the mental and physical health of those who suffer from them, with an incidence that is increasing worldwide. Most NDs result from a complex interaction of multiple genes and environmental factors such as stress or traumatic events, including the recent Coronavirus Disease (COVID-19) pandemic.
  • 567
  • 06 Nov 2023
Topic Review
Candidate Proteome-Based Biomarkers for Alzheimer’s Disease
Alzheimer’s disease (AD) is a devastating neurodegenerative disorder characterized by progressive cognitive decline and memory loss. Early and accurate diagnosis of AD is crucial for implementing timely interventions and developing effective therapeutic strategies. Proteome-based biomarkers have emerged as promising tools for AD diagnosis and prognosis due to their ability to reflect disease-specific molecular alterations. 
  • 416
  • 25 Oct 2023
  • Page
  • of
  • 49
>>